Recent advances in pediatric cancer research: An overview

Nan Hu

Tumor Discovery ›› 2025, Vol. 4 ›› Issue (4) : 1 -3.

PDF (354KB)
Tumor Discovery ›› 2025, Vol. 4 ›› Issue (4) :1 -3. DOI: 10.36922/TD025410108
EDITORIAL
research-article
Recent advances in pediatric cancer research: An overview
Author information +
History +
PDF (354KB)

Cite this article

Download citation ▾
Nan Hu. Recent advances in pediatric cancer research: An overview. Tumor Discovery, 2025, 4(4): 1-3 DOI:10.36922/TD025410108

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

World Health Organization (WHO). Childhood Cancer Drug Current Landscape and Pipeline Characteristics. Available from: https://www.who.int/observatories/global-observatory-on-health-research-and-development/monitoring/pediatric-cancer-drug-pipeline-characteristics?utm_source=chatgpt.com [Last accessed on 2025 Sep 30].

[2]

Nass SJ, Balogh E, Mendelsohn J. A national cancer clinical trials network: Recommendations from the institute of medicine. Am J Ther. 2011; 18(5):382-391. doi: 10.1097/MJT.0b013e3181ff7e23

[3]

Van Heerden J, Zaghloul M, Neven A, et al. Pediatric oncology clinical trials and collaborative research in Africa: Current landscape and future perspectives. JCO Glob Oncol. 2020; 6:1264-1275. doi: 10.1200/GO.20.00159

[4]

Godbole S, Voß H, Gocke A, et al. Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level. Nat Commun. 2024; 15(1):6237. doi: 10.1038/s41467-024-50554-z

[5]

Cheng C, Zhang L, Chang X, et al. Integrative proteogenomic characterization of Wilms tumor. Nat Commun. 2025; 16(1):7715. doi: 10.1038/s41467-025-62234-7

[6]

Grigore FN, Yang SJ, Chen CC, Koga T. Pioneering models of pediatric brain tumors. Neoplasia. 2023;36:100859. doi: 10.1016/j.neo.2022.100859

[7]

Lau LMS, Khuong-Quang DA, Mayoh C, et al. Precision- guided treatment in high-risk pediatric cancers. Nat Med. 2024; 30(7):1913-1922. doi: 10.1038/s41591-024-03044-0

[8]

Acanda De La Rocha AM, Berlow NE, et al. Feasibility of functional precision medicine for guiding treatment of relapsed or refractory pediatric cancers. Nat Med. 2024; 30(4):990-1000. doi: 10.1038/s41591-024-02848-4

[9]

Henrikson NB, Morrison CC, Blasi PR, Nguyen M, Shibuya KC, Patnode CD. Behavioral counseling for skin cancer prevention: Evidence report and systematic review for the US preventive services task force. JAMA. 2018; 319(11):1143-1157. doi: 10.1001/jama.2017.21630

[10]

Bezerra PMM, Sampaio MEA, Dos Santos FG, Ribeiro ILA, Santiago BM, de Sousa SA, Valença AMG. The effectiveness of an oral health education and prevention program on the incidence and severity of oral mucositis in pediatric cancer patients: A non-randomized controlled study. Support Care Cancer. 2021; 29(12):7877-7885. doi: 10.1007/s00520-021-06387-3

[11]

Ilowite MF, Cronin AM, Kang TI, Mack JW. Disparities in prognosis communication among parents of children with cancer: The impact of race and ethnicity. Cancer. 2017; 123(20):3995-4003. doi: 10.1002/cncr.30960

PDF (354KB)

4

Accesses

0

Citation

Detail

Sections
Recommended

/